WorkspaceResearch
MACTERPHARMACEUTICALSAlpha Score••Free accountSep-26

Macter International Ltd

Shariah compliant
Last close
Rs262.54
+2.80%
3 monthsAs of 13 Nov
BusinessSlowingGrowthShranklast yearValueCore planHealthStrongDividendSkipped

A strong balance sheet and the price in an uptrend. No dividend last year and priced above its peers.

Working

  • Debt is 34% of equity in the latest quarter.
  • Revenue up 12% on the same quarter last year.
  • Short-term assets cover short-term bills 1.8 times in the latest quarter.

To watch

  • P/E 19.2 against a sector median of 11.9.
  • Free cash flow negative, Rs 87m out last year, after Rs 243m the year before.
  • Profit down 34% on the same quarter last year.
Full analysis · free account

Keep reading MACTER: business, price trend and value

How good the business is, where its support zone sits, what it may be worth, its health, dividends, peers and latest results open with a free account.

Latest results

Quarter: Jul–Sep 2026

In the Jul–Sep 2026 quarter, MACTER's sales rose 12% to Rs 3.2bn, from Rs 2.9bn, and profit after tax fell 34% to Rs 95.9mn, from Rs 145.3mn (compared with Jul–Sep 2025).

Earnings per share were Rs 2.10, against Rs 3.22 a year earlier.

At Rs 262.54, MACTER trades at 15.3 times earnings.

P/E ratio
15.3
Dividend yield
0.0%
Dividend payout
0%
of earnings
Return on equity
15%
Net margin
5.0%
last 12 months
Debt to equity
0.34

MACTER quarterly results

Reported figures
QuarterSalesProfit after taxNet marginEPSDividend / share
Jul–Sep 2026Rs 3.2bnRs 95.9mn3.0%Rs 2.10—
Apr–Jun 2026Rs 2.9bnRs 145.9mn5.0%Rs 3.33—
Jan–Mar 2026Rs 2.9bnRs 92.5mn3.2%Rs 2.01—
Oct–Dec 2025Rs 3.5bnRs 291.5mn8.3%Rs 6.27—
Jul–Sep 2025Rs 2.9bnRs 145.3mn5.1%Rs 3.22—
Apr–Jun 2025Rs 2.7bnRs 298.8mn11.1%Rs 6.31Rs 2.00
Jan–Mar 2025Rs 2.5bnRs 91.2mn3.6%Rs 2.00Rs 1.80
Oct–Dec 2024Rs 2.9bnRs 308.5mn10.7%Rs 6.69—

MACTER annual results and dividends

Reported figures
YearSalesProfit after taxEPSDividend / share
Year to Jun 2026Rs 12.2bnRs 675.2mnRs 14.83—
Year to Jun 2025Rs 10.4bnRs 786.9mnRs 16.95Rs 3.80
Year to Jun 2024Rs 8.0bnRs 402.2mnRs 8.88Rs 2.25
Year to Jun 2023Rs 6.7bnRs 393.0mnRs 8.58Rs 1.08
Year to Jun 2022Rs 5.3bnRs 318.0mnRs 7.18Rs 3.21

Balance sheet and price

Balance sheet as of Sep 2026
Total assets
Rs 7.8bn
Shareholders' equity
Rs 4.3bn
Cash & bank
Rs 103.4mn
Total debt
Rs 1.4bn
Current ratio
1.84
3-month high
Rs 294.83
3-month low
Rs 222.29
1-month change
+6.6%
3-month change
-6.0%

Read more about MACTER

Other pharmaceuticals companies

MACTER: common questions

What is MACTER's share price?

Macter International Ltd (MACTER) last closed at Rs 262.54 on the Pakistan Stock Exchange.

Does MACTER pay a dividend?

Macter International Ltd reported no dividend for the year to Jun 2026.

What were MACTER's latest results?

In the Jul–Sep 2026 quarter, MACTER's sales rose 12% to Rs 3.2bn, from Rs 2.9bn, and profit after tax fell 34% to Rs 95.9mn, from Rs 145.3mn (compared with Jul–Sep 2025).

What is MACTER's P/E ratio?

At Rs 262.54, MACTER trades at 15.3 times its earnings.

Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.